HansBiomed Corporation (KOSDAQ:042520)
South Korea
· Delayed Price · Currency is KRW 6,780.00
-250.00 (-3.56%)
At close: Mar 28, 2025, 3:30 PM KST
HansBiomed Revenue
HansBiomed had revenue of 19.88B KRW in the quarter ending December 31, 2024, a decrease of -2.38%. This brings the company's revenue in the last twelve months to 80.65B, up 2.98% year-over-year. In the fiscal year ending September 30, 2024, HansBiomed had annual revenue of 81.14B with 3.98% growth.
Revenue (ttm)
80.65B
Revenue Growth
+2.98%
P/S Ratio
1.14
Revenue / Employee
309.02M
Employees
261
Market Cap
91.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 81.14B | 3.11B | 3.98% |
| Sep 30, 2023 | 78.03B | 3.57B | 4.80% |
| Sep 30, 2022 | 74.46B | 15.36B | 25.99% |
| Sep 30, 2021 | 59.10B | -21.00B | -26.22% |
| Sep 30, 2020 | 80.10B | 13.11B | 19.57% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |